Valeo Financial Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-268
Closed -$18K 726
2021
Q1
$18K Hold
268
﹤0.01% 1195
2020
Q4
$19K Hold
268
﹤0.01% 1037
2020
Q3
$10K Hold
268
﹤0.01% 1075
2020
Q2
$9K Hold
268
﹤0.01% 1307
2020
Q1
$6K Hold
268
﹤0.01% 1241
2019
Q4
$6K Hold
268
﹤0.01% 1225
2019
Q3
$6K Hold
268
﹤0.01% 1146
2019
Q2
$10K Sell
268
-68
-20% -$2.18K ﹤0.01% 1017
2019
Q1
$11K Sell
336
-97
-22% -$2.83K ﹤0.01% 934
2018
Q4
$11K Hold
433
﹤0.01% 853
2018
Q3
$11K Sell
433
-151
-26% -$2.83K ﹤0.01% 934
2018
Q2
$10K Buy
584
+28
+5% +$321 ﹤0.01% 933
2018
Q1
$4K Hold
556
﹤0.01% 1184
2017
Q4
$4K Sell
556
-299
-35% -$1.86K ﹤0.01% 1061
2017
Q3
$3K Buy
+855
New +$1.8K ﹤0.01% 944

Other funds holding CDNA

Valeo Financial Advisors's CDNA Position: Q2 2021 in Review

Valeo Financial Advisors sold out of CareDx (CDNA) in Q2 2021, closing a stake of 268 shares — an estimated $18K sold.

Valeo Financial Advisors first reported a position in CDNA in Q3 2017 and held it in 15 quarters. The position peaked at $19K in Q4 2020. 254 funds tracked by Wall St. Rank hold CDNA as of Q2 2021.

  • Valeo Financial Advisors reported no remaining CareDx position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 268 CareDx shares in Q2 2021, an estimated $18K.
  • Valeo Financial Advisors first reported a position in CareDx in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's CareDx position peaked at $19K in Q4 2020.
  • 254 funds tracked by Wall St. Rank held CareDx as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.